Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,058.00
Bid: 12,058.00
Ask: 12,060.00
Change: -98.00 (-0.81%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,036.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

African Union backs call to waive IP rights on COVID-19 drugs

Thu, 25th Feb 2021 11:01

JOHANNESBURG, Feb 25 (Reuters) - The African Union is
backing calls for drugmakers to waive some intellectual property
rights on COVID-19 medicines and vaccines to speed up their
rollout to poor countries, the head of its disease control body
said on Thursday.

South Africa and India, which both manufacture drugs and
vaccines, made the proposal at the World Trade Organization
(WTO) last year, arguing that intellectual property (IP) rules
were hindering the urgent scale-up of vaccine production and
provision of medical products to some patients.

They have faced opposition from some developed nations, but
the backing of the African Union (AU) may give renewed impetus
for the push to relax IP rules.

John Nkengasong, director of the Africa Centers for Disease
Control and Prevention, told a news conference that IP transfer
was a "win-win for everybody" that would address the huge
inequalities in global public health.

He gave two examples where the developing world had suffered
because of restricted access to medicines: the swine flu
pandemic in the late 2000s and HIV/AIDS in the 1990s.

"In 1996, HIV drugs were available, and we saw how mortality
in the developed world decreased drastically. But it would take
10 years before those drugs were accessible in Africa in any
meaningful way," he said.

"In between, 12 million Africans died, so I just use those
numbers to say: any IP transfer will be beneficial to everybody,
because nobody wants to sit back and be proud of that sad event
... We want to be on the right side of history."

Nkengasong added the Africa CDC's regulatory taskforce had
approved two versions of AstraZeneca's COVID-19 vaccine
for emergency use, a day after Ghana received its first
AstraZeneca doses from global vaccine distribution facility
COVAX.

He said the developers of Russia's Sputnik V vaccine had
submitted a "full dossier" of data to the Africa CDC and that in
the coming days an expert panel would review the data and make a
pronouncement.

"We have not received dossiers yet from China colleagues,
but we remain optimistic that they will submit to us," he
continued.

Several countries on the continent, including Egypt,
Zimbabwe and Senegal, have already started rolling out Chinese
COVID-19 shots.
(Reporting by Alexander Winning in Johannesburg and Omar
Mohammed in Nairobi
Editing by Joe Bavier and Mark Potter)

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.